Global Ibrutinib Market Research Report 2018

January 2018 | 105 pages | ID: GA25AB468E1EN
QYResearch

Abstracts

In this report, the global Ibrutinib market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ibrutinib in these regions, from 2013 to 2025 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Ibrutinib market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pharmacyclics, Inc.
• Janssen Biotech, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 140 mg
• 10 mg
• 5 mg

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Chronic Lymphocytic Leukaemia (CLL)
• Mantle Cell Lymphoma (MCL)
• Diffuse Large B Cell Lymphoma (DLBCL)
• Multiple Myeloma (MM)
• Follicular Lymphoma (FL)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Ibrutinib Market Research Report 2018

1 IBRUTINIB MARKET OVERVIEW

1.1 Product Overview and Scope of Ibrutinib
1.2 Ibrutinib Segment by Type (Product Category)
  1.2.1 Global Ibrutinib Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Ibrutinib Production Market Share by Type (Product Category) in 2017
  1.2.3 140 mg
  1.2.4 10 mg
  1.2.5 5 mg
1.3 Global Ibrutinib Segment by Application
  1.3.1 Ibrutinib Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Chronic Lymphocytic Leukaemia (CLL)
  1.3.3 Mantle Cell Lymphoma (MCL)
  1.3.4 Diffuse Large B Cell Lymphoma (DLBCL)
  1.3.5 Multiple Myeloma (MM)
  1.3.6 Follicular Lymphoma (FL)
1.4 Global Ibrutinib Market by Region (2013-2025)
  1.4.1 Global Ibrutinib Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Ibrutinib (2013-2025)
  1.5.1 Global Ibrutinib Revenue Status and Outlook (2013-2025)
  1.5.2 Global Ibrutinib Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL IBRUTINIB MARKET COMPETITION BY MANUFACTURERS

2.1 Global Ibrutinib Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Ibrutinib Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Ibrutinib Production and Share by Manufacturers (2013-2018)
2.2 Global Ibrutinib Revenue and Share by Manufacturers (2013-2018)
2.3 Global Ibrutinib Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Ibrutinib Manufacturing Base Distribution, Sales Area and Product Type
2.5 Ibrutinib Market Competitive Situation and Trends
  2.5.1 Ibrutinib Market Concentration Rate
  2.5.2 Ibrutinib Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL IBRUTINIB CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Ibrutinib Capacity and Market Share by Region (2013-2018)
3.2 Global Ibrutinib Production and Market Share by Region (2013-2018)
3.3 Global Ibrutinib Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL IBRUTINIB SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Ibrutinib Consumption by Region (2013-2018)
4.2 North America Ibrutinib Production, Consumption, Export, Import (2013-2018)
4.3 Europe Ibrutinib Production, Consumption, Export, Import (2013-2018)
4.4 China Ibrutinib Production, Consumption, Export, Import (2013-2018)
4.5 Japan Ibrutinib Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Ibrutinib Production, Consumption, Export, Import (2013-2018)
4.7 India Ibrutinib Production, Consumption, Export, Import (2013-2018)

5 GLOBAL IBRUTINIB PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Ibrutinib Production and Market Share by Type (2013-2018)
5.2 Global Ibrutinib Revenue and Market Share by Type (2013-2018)
5.3 Global Ibrutinib Price by Type (2013-2018)
5.4 Global Ibrutinib Production Growth by Type (2013-2018)

6 GLOBAL IBRUTINIB MARKET ANALYSIS BY APPLICATION

6.1 Global Ibrutinib Consumption and Market Share by Application (2013-2018)
6.2 Global Ibrutinib Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL IBRUTINIB MANUFACTURERS PROFILES/ANALYSIS

7.1 Pharmacyclics, Inc.
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Ibrutinib Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pharmacyclics, Inc. Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Janssen Biotech, Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Ibrutinib Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Janssen Biotech, Inc. Ibrutinib Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview

8 IBRUTINIB MANUFACTURING COST ANALYSIS

8.1 Ibrutinib Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ibrutinib

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ibrutinib Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ibrutinib Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IBRUTINIB MARKET FORECAST (2018-2025)

12.1 Global Ibrutinib Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Ibrutinib Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Ibrutinib Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Ibrutinib Price and Trend Forecast (2018-2025)
12.2 Global Ibrutinib Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Ibrutinib Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Ibrutinib Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Ibrutinib Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Ibrutinib Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Ibrutinib Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Ibrutinib Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Ibrutinib Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Ibrutinib Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ibrutinib
Figure Global Ibrutinib Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Ibrutinib Production Market Share by Types (Product Category) in 2017
Figure Product Picture of 140 mg
Table Major Manufacturers of 140 mg
Figure Product Picture of 10 mg
Table Major Manufacturers of 10 mg
Figure Product Picture of 5 mg
Table Major Manufacturers of 5 mg
Figure Global Ibrutinib Consumption (K Units) by Applications (2013-2025)
Figure Global Ibrutinib Consumption Market Share by Applications in 2017
Figure Chronic Lymphocytic Leukaemia (CLL) Examples
Table Key Downstream Customer in Chronic Lymphocytic Leukaemia (CLL)
Figure Mantle Cell Lymphoma (MCL) Examples
Table Key Downstream Customer in Mantle Cell Lymphoma (MCL)
Figure Diffuse Large B Cell Lymphoma (DLBCL) Examples
Table Key Downstream Customer in Diffuse Large B Cell Lymphoma (DLBCL)
Figure Multiple Myeloma (MM) Examples
Table Key Downstream Customer in Multiple Myeloma (MM)
Figure Follicular Lymphoma (FL) Examples
Table Key Downstream Customer in Follicular Lymphoma (FL)
Figure Global Ibrutinib Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Ibrutinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Ibrutinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Ibrutinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Ibrutinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Ibrutinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Ibrutinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Ibrutinib Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Ibrutinib Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Ibrutinib Major Players Product Capacity (K Units) (2013-2018)
Table Global Ibrutinib Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Ibrutinib Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Ibrutinib Capacity (K Units) of Key Manufacturers in 2017
Figure Global Ibrutinib Capacity (K Units) of Key Manufacturers in 2018
Figure Global Ibrutinib Major Players Product Production (K Units) (2013-2018)
Table Global Ibrutinib Production (K Units) of Key Manufacturers (2013-2018)
Table Global Ibrutinib Production Share by Manufacturers (2013-2018)
Figure 2017 Ibrutinib Production Share by Manufacturers
Figure 2017 Ibrutinib Production Share by Manufacturers
Figure Global Ibrutinib Major Players Product Revenue (Million USD) (2013-2018)
Table Global Ibrutinib Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Ibrutinib Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Ibrutinib Revenue Share by Manufacturers
Table 2018 Global Ibrutinib Revenue Share by Manufacturers
Table Global Market Ibrutinib Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Ibrutinib Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Ibrutinib Manufacturing Base Distribution and Sales Area
Table Manufacturers Ibrutinib Product Category
Figure Ibrutinib Market Share of Top 3 Manufacturers
Figure Ibrutinib Market Share of Top 5 Manufacturers
Table Global Ibrutinib Capacity (K Units) by Region (2013-2018)
Figure Global Ibrutinib Capacity Market Share by Region (2013-2018)
Figure Global Ibrutinib Capacity Market Share by Region (2013-2018)
Figure 2017 Global Ibrutinib Capacity Market Share by Region
Table Global Ibrutinib Production by Region (2013-2018)
Figure Global Ibrutinib Production (K Units) by Region (2013-2018)
Figure Global Ibrutinib Production Market Share by Region (2013-2018)
Figure 2017 Global Ibrutinib Production Market Share by Region
Table Global Ibrutinib Revenue (Million USD) by Region (2013-2018)
Table Global Ibrutinib Revenue Market Share by Region (2013-2018)
Figure Global Ibrutinib Revenue Market Share by Region (2013-2018)
Table 2017 Global Ibrutinib Revenue Market Share by Region
Figure Global Ibrutinib Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Southeast Asia Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table India Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Ibrutinib Consumption (K Units) Market by Region (2013-2018)
Table Global Ibrutinib Consumption Market Share by Region (2013-2018)
Figure Global Ibrutinib Consumption Market Share by Region (2013-2018)
Figure 2017 Global Ibrutinib Consumption (K Units) Market Share by Region
Table North America Ibrutinib Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Ibrutinib Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Ibrutinib Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Ibrutinib Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Ibrutinib Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Ibrutinib Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Ibrutinib Production (K Units) by Type (2013-2018)
Table Global Ibrutinib Production Share by Type (2013-2018)
Figure Production Market Share of Ibrutinib by Type (2013-2018)
Figure 2017 Production Market Share of Ibrutinib by Type
Table Global Ibrutinib Revenue (Million USD) by Type (2013-2018)
Table Global Ibrutinib Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Ibrutinib by Type (2013-2018)
Figure 2017 Revenue Market Share of Ibrutinib by Type
Table Global Ibrutinib Price (USD/Unit) by Type (2013-2018)
Figure Global Ibrutinib Production Growth by Type (2013-2018)
Table Global Ibrutinib Consumption (K Units) by Application (2013-2018)
Table Global Ibrutinib Consumption Market Share by Application (2013-2018)
Figure Global Ibrutinib Consumption Market Share by Applications (2013-2018)
Figure Global Ibrutinib Consumption Market Share by Application in 2017
Table Global Ibrutinib Consumption Growth Rate by Application (2013-2018)
Figure Global Ibrutinib Consumption Growth Rate by Application (2013-2018)
Table Pharmacyclics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharmacyclics, Inc. Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pharmacyclics, Inc. Ibrutinib Production Growth Rate (2013-2018)
Figure Pharmacyclics, Inc. Ibrutinib Production Market Share (2013-2018)
Figure Pharmacyclics, Inc. Ibrutinib Revenue Market Share (2013-2018)
Table Janssen Biotech, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech, Inc. Ibrutinib Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Biotech, Inc. Ibrutinib Production Growth Rate (2013-2018)
Figure Janssen Biotech, Inc. Ibrutinib Production Market Share (2013-2018)
Figure Janssen Biotech, Inc. Ibrutinib Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ibrutinib
Figure Manufacturing Process Analysis of Ibrutinib
Figure Ibrutinib Industrial Chain Analysis
Table Raw Materials Sources of Ibrutinib Major Manufacturers in 2017
Table Major Buyers of Ibrutinib
Table Distributors/Traders List
Figure Global Ibrutinib Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Ibrutinib Price (Million USD) and Trend Forecast (2018-2025)
Table Global Ibrutinib Production (K Units) Forecast by Region (2018-2025)
Figure Global Ibrutinib Production Market Share Forecast by Region (2018-2025)
Table Global Ibrutinib Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Ibrutinib Consumption Market Share Forecast by Region (2018-2025)
Figure North America Ibrutinib Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Ibrutinib Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Ibrutinib Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Ibrutinib Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Ibrutinib Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Ibrutinib Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Ibrutinib Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Ibrutinib Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Ibrutinib Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Ibrutinib Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Ibrutinib Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Ibrutinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Ibrutinib Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Ibrutinib Production (K Units) Forecast by Type (2018-2025)
Figure Global Ibrutinib Production (K Units) Forecast by Type (2018-2025)
Table Global Ibrutinib Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Ibrutinib Revenue Market Share Forecast by Type (2018-2025)
Table Global Ibrutinib Price Forecast by Type (2018-2025)
Table Global Ibrutinib Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Ibrutinib Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source